NIH-funded research R15 grant

Understanding how Leishmania parasites use lipids to survive and infect hosts

Official title: Phospholipid metabolism in Leishmania

Funded at Texas Tech University · NIH-10974778 · Data updated 2026-11-12

This study is looking at how Leishmania parasites get the fats they need to survive while living in both sandflies and humans, and it hopes to find new ways to treat infections caused by these parasites.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionTexas Tech University
NIH-funded
Lab location1 site (Lubbock, United States)
Project startSeptember 1, 2021
Project endAugust 31, 2027
Funding year2024
Award (this year)$498,722
NIH project number2R15AI156746-02
Project IDNIH-10974778 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals infected with Leishmania or those at risk of infection, particularly in endemic regions.

Less likely to help

Patients who are not infected with Leishmania or do not have a risk of exposure to the parasite may not benefit from this research.

What this research studies

This research investigates the lipid metabolism of Leishmania parasites, which alternate between different life stages in sandflies and mammals. By studying how these parasites acquire essential lipids from their mammalian hosts, the research aims to uncover new insights into the interactions between Leishmania and its hosts. The project focuses on the role of specific enzymes, such as ethanolamine-phosphate cytidylyltransferase (EPCT), in the survival and pathogenicity of these parasites. The findings could lead to the identification of novel drug targets to combat Leishmania infections.

Why it matters

Potential benefit: If successful, this research could lead to the development of new treatments for Leishmania infections, which currently lack effective vaccines and have limited treatment options.

How similar studies have gone: Previous research has shown promising results in understanding lipid metabolism in other parasitic infections, suggesting potential for success in this area as well.

Where this research is happening

  • Texas Tech University
    Lubbock, United States
    Active

Researchers

  • Principal investigator: Zhang, Kai — Texas Tech University
  • Study coordinator: Zhang, Kai

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.